Jens Erik Nielsen-Kudsk

Noninvasive assessment of nitrate tolerance using mitral Doppler and brachial artery ultrasonography.

Effects of L-glutamate supplementation mimic effects of fasting in the ischemic heart.

Glibenclamide blunts coronary flow reserve induced by adenosine and dipyridamole.

Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism.

Effects of KATP channel modulation on myocardial glycogen content, lactate, and amino acids in nonischemic and ischemic rat hearts.

A phase of increased ST elevation during coronary occlusion following ischemic preconditioning.

Effects of levosimendan on myocardial infarct size and hemodynamics in a closed-chest porcine ischemia-reperfusion model.

Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides.

Ventricular septal rupture complicating acute myocardial infarction: clinical characteristics and contemporary outcome.

Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart.

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.

Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.

Fatal giant cell myocarditis in a patient with multiple autoimmune disorders.

Pulmonary hypertension due to a large acquired systemic arteriovenous fistula.

Closure of secundum atrial septal defects in the adult and elderly patients.

Ischemic preconditioning reduces right ventricular infarct size through opening of mitochondrial potassium channels.

First experiences with the GORE(®) Septal Occluder in children and adults with atrial septal defects.

Is closure of atrial septal defects in adults still controversial?

Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning.

Internal mammary arteriovenous fistula found late after aortic root replacement.

Pulmonary hypertension in chronic obstructive and interstitial lung diseases.

Acute effects of sildenafil and dobutamine in the hypertrophic and failing right heart in vivo.

Risk of pneumonia in adults with closed versus unclosed atrial septal defect (from a nationwide cohort study).

Effects of bisoprolol and losartan treatment in the hypertrophic and failing right heart.

Long-term outcome after transcatheter closure of postinfarction ventricular septal rupture.

Adverse events in transcatheter interventions for congenital heart disease: a population-based long-term study.

[In Process Citation].

Acute effects of levosimendan in experimental models of right ventricular hypertrophy and failure.

Limitations and pitfalls in measurements of right ventricular stroke volume in an animal model of right heart failure.

Evaluation of cardiac electrophysiological properties in an experimental model of right ventricular hypertrophy and failure.

Survival in an incident cohort of patients with pulmonary arterial hypertension in Denmark.

Closure of a patent foramen ovale in patients with platypnoea-orthodeoxia: a rare and overlooked cause of dyspnoea and hypoxaemia.

Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation.

Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥ 75 Years.

Left main coronary artery compression in pulmonary arterial hypertension.

Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.

sGC-cGMP-PKG pathway stimulation protects the healthy but not the failing right ventricle of rats against ischemia and reperfusion injury.

Inotropic Effects of Prostacyclins on the Right Ventricle Are Abolished in Isolated Rat Hearts With Right-Ventricular Hypertrophy and Failure.

Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion.

Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy.

Percutaneous balloon valvuloplasty in carcinoid pulmonary valve stenosis.

Transcatheter Mitral Paravalvular Leak Closure Facilitated by Preprocedural Cardiac CT for Simulation of Fluoroscopic Anatomy and Paravalvular Defect Localization.

Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry.

Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.

Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study.

Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study.

Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark.

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).

Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heart.

The renin-angiotensin-aldosterone-system and right heart failure in congenital heart disease.

Levosimendan Prevents and Reverts Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension.

Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences.

High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation.

Intracardiac Echocardiography From the Left Atrium for Procedural Guidance of Transcatheter Left Atrial Appendage Occlusion.

A porcine in-vivo model of acute pulmonary embolism.

Left atrial appendage occlusion is promising, not concerning.

Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.

Levosimendan improves cardiac function and myocardial efficiency in rats with right ventricular failure.

Catheter-based therapies in acute pulmonary embolism.

Long-term mortality in patients with atrial septal defect: a nationwide cohort-study.

Cardiac Computed Tomography for Left Atrial Appendage Occlusion: Acquisition, Analysis, Advantages, and Limitations.

Levosimendan in pulmonary hypertension and right heart failure.

Can computer assisted analysis of a standard 12‑lead ECG be used for early diagnosis and monitoring of disease progression in pulmonary hypertension?

Large Solid Right Atrial Thrombus Treated by AngioVac Catheter-Based Suction Thrombectomy.

Right Ventricular Fibrosis.

Lifelong burden of small unrepaired atrial septal defect: Results from the Danish National Patient Registry.

Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidone.

Riociguat, sildenafil and inhaled nitric oxide reduces pulmonary vascular resistance and improves right ventricular function in a porcine model of acute pulmonary embolism.

Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry.

Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure.

Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study.

Use of Intracardiac Compared With Transesophageal Echocardiography for Left Atrial Appendage Occlusion in the Amulet Observational Study.

Impact of pulmonary endarterectomy on pulmonary arterial wave propagation and reservoir function.

Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.

Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study.

Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.

Expert Recommendations on Cardiac Computed Tomography for Planning Transcatheter Left Atrial Appendage Occlusion.

Effects of 6-mercaptopurine in pressure overload induced right heart failure.

Pulmonary vasodilation in acute pulmonary embolism - a systematic review.

Terlipressin Increases Systemic and Lowers Pulmonary Arterial Pressure in Experimental Acute Pulmonary Embolism.

Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study.

Spontaneously occluded left atrial appendage in a patient with atrial fibrillation and stroke: a case report.

Right ventricular adaptation in the critical phase after acute intermediate-risk pulmonary embolism.

Direct Oral Anticoagulants After Percutaneous Patent Foramen Ovale (PFO) Closure: A Call for Caution.

Left atrial appendage occlusion with the Amulet device: to tug or not to tug?

Inhaled nitric oxide has pulmonary vasodilator efficacy both in the immediate and prolonged phase of acute pulmonary embolism.

Correction to: Left atrial appendage occlusion with the Amulet device: to tug or not to tug?

The authors reply.

The Impact of CHADS-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study.

The echocardiographic ratio tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure predicts short-term adverse outcomes in acute pulmonary embolism.

Impact of Preload on Right Ventricular Hemodynamics in Acute Pulmonary Embolism.

Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational Study.

The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation.

Left atrial appendage occlusion in COVID-19 times.

Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.

Peridevice Leak Following Amplatzer Left Atrial Appendage Occlusion: Cardiac Computed Tomography Classification and Clinical Outcomes.

Left atrial appendage occlusion in chicken-wing anatomies: Imaging assessment, procedural, and clinical outcomes of the "sandwich technique".

Inhaled nitric oxide has pulmonary vasodilator efficacy both in the immediate and prolonged phase of acute pulmonary embolism.

Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial.

Oxygen Therapy Lowers Right Ventricular Afterload in Experimental Acute Pulmonary Embolism.

Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet Observational Post-Market Study.

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism.

Comparison of deep learning, radiomics and subjective assessment of chest CT findings in SARS-CoV-2 pneumonia.

Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.

Predicting factors for pulmonary embolism response team activation in a general pulmonary embolism population.

Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.

Gender difference in left atrial appendage occlusion outcomes: Results from the Amplatzer™ Amulet™ Observational Study.

Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.

Prevention of Left Atrial Appendage Device-Related Thrombosis: Is Reduced-Dose Direct Oral Anticoagulation the Way Forward?

Putative Biomarkers for Acute Pulmonary Embolism in Exhaled Breath Condensate.

Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study.

The Art of Planning a Left Atrial Appendage Closure: Will Computational Modeling Simplify the Intervention?

Left atrial appendage occlusion in haemophilia patients with atrial fibrillation.

Effects of mechanical ventilation versus apnea on bi-ventricular pressure-volume loop recording.

The Case for Intracardiac Echo to Guide Left Atrial Appendage Closure.

Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.

Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry.

Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy.

Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.

Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions.

Usefulness of a novel sizing chart for left atrial appendage occlusion with the Amplatzer Amulet.

Correction to: Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.

Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing?

Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.

Left Atrial Appendage Occlusion: Sex Matters, But Not in the Long Run.

Adults with small, unrepaired atrial septal defects have reduced cardiac index during exercise.

Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial.

Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study.

Intracardiac Echocardiography to Guide Watchman FLX Implantation: The ICE LAA Study.

Transcatheter Intervention for Coarctation of the Aorta: A Nordic Population-Based Registry With Long-Term Follow-Up.

Peridevice Leak After Left Atrial Appendage Occlusion: Incidence, Mechanisms, Clinical Impact, and Management.

Impact of Computational Modeling on Transcatheter Left Atrial Appendage Closure Efficiency and Outcomes.

The Case for Intracardiac Echo to Guide Left Atrial Appendage Closure.

Biomarkers of collagen turnover and wound healing in chronic thromboembolic pulmonary hypertension patients before and after pulmonary endarterectomy.

Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study.

Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry.

Diagnostic and therapeutic pathways for the malignant left atrial appendage: European Heart Rhythm Association physician survey.

Right-to-left ventricular ratio is higher in systole than diastole in patients with acute pulmonary embolism.

Ischemic Stroke Related to a Patent Foramen Ovale Occurs in the Morning Hours.

Impact of Device Implant Depth After Left Atrial Appendage Occlusion.

Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders.

3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).

A porcine model of human-like chronic thromboembolic pulmonary disease.

Computed tomography-based device-sizing in Amplatzer Amulet left atrial appendage occlusion.

Device-Related Thrombus After Left Atrial Appendage Occlusion: Clinical Impact, Predictors, Classification, and Management.

Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.

Left atrial appendage occlusion guided by intracardiac echocardiography in a patient with a 34 mm atrial septal defect occluder: a case report.

Effects of empagliflozin on right ventricular adaptation to pressure overload.

Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper.

Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management.

Single antiplatelet therapy following Amplatzer left atrial appendage occlusion.

Changes in Pulmonary Vascular Resistance and Obstruction Score Following Acute Pulmonary Embolism in Pigs.

First-in-human left atrial appendage closure using the WATCHMAN FLX Pro device: a case report.

Immediate cardiopulmonary responses to consecutive pulmonary embolism: a randomized, controlled, experimental study.

Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.

Long-term cardiac computed tomography follow-up after left atrial appendage occlusion.

Left Atrial Appendage Occlusion: Current Advances and Remaining Challenges.

Real changes in left atrial appendage occlusion practice in Denmark over time or inappropriate use of registry data?

Right ventricular diastolic adaptation to pressure overload in different rat strains.

Understanding the role of the left atrial appendage on the flow in the atrium.

Impact of gender in patients with device-related thrombosis after left atrial appendage closure - A sub-analysis from the multicenter EUROC-DRT-registry.

Position Statement on Cardiac Computed Tomography Following Left Atrial Appendage Occlusion.

Recurrent Ischemic Stroke/Transient Ischemic Attack After Patent Foramen Ovale Closure: A cohort study.

Reproducibility of Cardiac Computed Tomography Classifications of Hypoattenuated Thickening and Peridevice Leak Following Left Atrial Appendage Closure.